BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/21/2023 9:36:24 AM | Browse: 415 | Download: 1181
Publication Name World Journal of Virology
Manuscript ID 80940
Country Türkiye
ISSN 2220-3249 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type Letter to the Editor
Article Title Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
Manuscript Source Unsolicited Manuscript
All Author List Ali Osman Gulmez and Sonay Aydın
ORCID
Author(s) ORCID Number
Ali Osman Gulmez http://orcid.org/0000-0001-7050-1765
Sonay Aydın http://orcid.org/0000-0002-3812-6333
Funding Agency and Grant Number
Corresponding Author Ali Osman Gulmez, MD, Academic Research, Department of Radiology, Erzincan University, Erzincan University, Mengucek Gazi Education and Research Hospital, Başbağlar Mahallesi Hacı Ali Akın Caddesi No. 32 Erzincan/Merkez, Erzincan 24100, ERZINCAN 24100, CENTRE, Türkiye. aliosmangulmez.2@gmail.com
Key Words cardiac bioenzymes; COVID-19; Treatment; Diagnosis; triple rule-out computed tomography angiography (TRO CTA); Dual Energy Computed Tomography (DECT)
Core Tip Recommends biomarkers, especially troponin, in patients with COVID-19-associated myocarditis and other myocardial damage; however, they have proven that in addition to traditional biomarkers, new cardiac bioenzymes such as prepesin, ST2 and copeptin also increase and significantly worsen the prognosis. Knowing this, evaluation together with other imaging methods is also important in diagnosis.
Publish Date 2023-03-21 09:36
Citation Gulmez AO, Aydın S. Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2. World J Virol 2023; 12(2): 132-135
URL https://www.wjgnet.com/2220-3249/full/v12/i2/132.htm
DOI https://dx.doi.org/10.5501/wjv.v12.i2.132
Full Article (PDF) WJV-12-132.pdf
Full Article (Word) WJV-12-132.docx